Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avalon GloboCare (ALBT) Cash & Equivalents (2016 - 2025)

Avalon GloboCare's Cash & Equivalents history spans 10 years, with the latest figure at $109091.0 for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 95.9% year-over-year to $109091.0; the TTM value through Dec 2025 reached $109091.0, down 95.9%, while the annual FY2025 figure was $109091.0, 95.9% down from the prior year.
  • Cash & Equivalents reached $109091.0 in Q4 2025 per ALBT's latest filing, down from $333931.0 in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $3.9 million in Q3 2022 to a low of $76491.0 in Q4 2023.
  • Average Cash & Equivalents over 5 years is $975702.2, with a median of $669247.5 recorded in 2021.
  • Peak YoY movement for Cash & Equivalents: plummeted 96.16% in 2023, then surged 3375.16% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $807538.0 in 2021, then skyrocketed by 146.54% to $2.0 million in 2022, then tumbled by 96.16% to $76491.0 in 2023, then soared by 3375.16% to $2.7 million in 2024, then plummeted by 95.9% to $109091.0 in 2025.
  • Per Business Quant, the three most recent readings for ALBT's Cash & Equivalents are $109091.0 (Q4 2025), $333931.0 (Q3 2025), and $201532.0 (Q2 2025).